Cabometyx-TU (Cabozantinib Tablet) 20mg

Cabometyx-TU (Cabozantinib) 20mg tablets support cancer treatment by targeting tumor growth pathways. This targeted therapy is prescribed for advanced renal cell carcinoma and other solid tumors. Ideal for patients seeking precision oncology options. Cabozantinib tablets 20mg offer a convenient oral solution.

Strength

20mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Gen Ilac

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cabometyx-TU (Cabozantinib) 20mg tablets are used to treat advanced kidney cancer and certain thyroid cancers. This targeted therapy works by blocking signals that fuel tumor growth and blood vessel formation. Patients with progressive solid tumors may benefit from cabozantinib’s mechanism. It is prescribed when standard treatments are no longer effective.

Side Effects

Common effects of Cabometyx-TU (Cabozantinib) 20mg tablets include fatigue, diarrhea, and decreased appetite. Some users report changes in taste or mouth sores during treatment. Hand-foot syndrome and high blood pressure may also occur. These effects vary by individual and are typically monitored by healthcare providers.

Precautions & Warnings

Keep Cabometyx-TU (Cabozantinib) 20mg tablets at room temperature away from moisture and heat. Store in the original blister pack until use to protect from light. Do not crush, split, or chew tablets. Handle with care and keep out of reach of children and pets. Report any unusual symptoms to a healthcare professional promptly.

Avoid Interactions

Cabometyx-TU (Cabozantinib) 20mg tablets may interact with strong CYP3A4 inhibitors or inducers, altering drug levels in the body. Avoid grapefruit products and St. John’s wort during treatment. Blood thinners, NSAIDs, and certain antibiotics may also affect or be affected by cabozantinib. Always inform your doctor about all medications being taken.

Frequently Asked Questions

Cabometyx-TU (Cabozantinib) 20mg tablets are used to treat advanced kidney cancer and certain thyroid cancers.

Store Cabometyx-TU 20mg tablets at room temperature in the original blister pack away from moisture and light.

No, Cabometyx-TU 20mg tablets should not be crushed, split, or chewed.

Common side effects include fatigue, diarrhea, decreased appetite, and hand-foot syndrome.

Yes, grapefruit products may interact with Cabometyx-TU and should be avoided.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.